[1]邵滢,王秋月.Mir-217/Sirt1通路与糖尿病肾病[J].国际内分泌代谢杂志,2015,(02):124-126.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
　Shao Ying,Wang Qiuyue..Mir-217 / Sirt1 pathway and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):124-126.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]

点击复制

Mir-217/Sirt1通路与糖尿病肾病()

分享到：

参考文献/References:

[1]　Shi SL，Yu LP，Zhang TR，et al.Smad2-dependent downregula-tion of miR-30 is required for TGF-beta-induced apoptosis in podocytes[J].PLoS One，2013，8（9）：e75572. 　
[2]　Fiorentino L，Cavalera M，Mavilio M，et al.Regulation of TIMP3 in diabetic nephropathy：a role for microRNAs[J].Acta Diabetol，2013，50（6）：965-969. 　
[3]　Staszel T，Zapala B，Polus AA，et al.Role of microRNAs in endothelial cell pathophysiology[J].Pol Arch Med Wewn，2011， 121（10）：361-366. 　
[4]　Marcinkowska M，Szymanski M，Krzyzosiak WJ，et al.Copy number variation of microRNA genes in the human genome[J].BMC Genomics，2011，12：183. 　
[5]　Zhang L，He SY，Guo SD，et al.Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hyper-trophy in early diabetic nephropathy mice by targeting GAS1[J].J Diabetes Complications，2014，28（3）：259-264. 　
[6]　Su J，Wang Q，Liu YP，et al.miR-217 inhibits invasion of hepa-tocellular carcinoma cells through direct suppression of E2F3 [J].Mol Cell Biochem，2014，392（1-2）：289-296. 　
[7]　Goodwin D，Rosenzweig B，Zhang J，et al.Evaluation of miR-216a and miR-217 as potential biomarkers of acute pancreatic injury in rats and mice[J].Biomarkers，2014，19（6）：517-529. 　
[8]　Saldanha JF，Leal VD，Stenvinkel PA，et al.Resveratrol：why is it a promising therapy for chronic kidney disease patients?[J].Oxid Med Cell Longev，2013，2013：963217. 　
[9]　Kume S，Kitada M，Kanasaki K，et al.Anti-aging molecule， Sirt1：a novel therapeutic target for diabetic nephropathy[J].Arch Pharm Res，2013，36（2）：230-236.
[10]　Hasegawa K，Wakino S，Simic P，et al.Renal tubular Sirt1 atten-uates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes[J].Nat Med，2013，19（11）： 1496-1504.
[11]　Polak-Jonkisz D，Laszki-Szczachor K，Rehan L，et al.Nephropro-tective action of sirtuin 1 （SIRT1）[J].J Physiol Biochem，2013，69（4）：957-961.
[12]　Xu Y，Nie L，Yin YG，et al.Resveratrol protects against hyper-glycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells[J].Toxicol Appl Pharmacol，2012， 259（3）：395-401.
[1３]　Wu L，Zhang Y，Ma X，et al.The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats[J].Mol Biol Rep，2012，39（9）：9085-9093.
[1４]　Kim MY，Lim JH，Youn HH，et al.Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db/db mice[J].Diabetologia，2013，56（1）：204-217.
[1５]　Vasko R，Xavier S，Chen J，et al.Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14：relevance to fibrosis of vascular senes-cence[J].J Am Soc Nephrol，2014，25（2）：276-291.
[1６]　Liang J，Tian SF，Han JX，et al.Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction[J].Ren Fail，2014，36（2）：285-291.
[1７]　Huang XZ，Wen D，Zhang M，et al.Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-beta/Smad3 pathway[J].J Cell Biochem，2014，115（5）：996-1005.
[1８]　Nie YN，Li SY，Yi YE，et al.Effects of astragalus injection on the TGF beta/Smad pathway in the kidney in type 2 diabetic mice[J].BMC Complement Altern Med，2014，14：148.
[1９]　Liu M，Liu F.Resveratrol inhibits mTOR signaling by targeting DEPTOR[J].Commun Integr Biol，2011，4（4）：382-384.
[20]　Liu L，Hu X，Cai GY，et al.High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling[J].Nephrol Dial Transplant，2012，27（1）：90-100.
[21]　Zhang S，Liu L，Wang R，et al.MicroRNA-217 promotes angio-genesis of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and FOXO3A[J].PLoS One，2013，8（12）：e83620.
[22]　Yin HQ，Hu M，Zhang R，et al.MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1[J].J Biol Chem，2012，287（13）：9817-9826.
[2３]　Zhang HS，Wu TC，Sang WW，et al.MiR-217 is involved in Tat-induced HIV-1 long terminal repeat （LTR） transactivation by down-regulation of SIRT1[J].Biochim Biophys Acta，2012， 1823（5）：1017-1023.
[2４]　Menghini R，Casagrande V，Cardellini MA，et al.MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1[J].Circulation，2009，120（15）：1524-1532.